Poster: ABCL-320 Initial Safety Run-In Results of the Phase 3 LOTIS-5 Trial: Novel Combination of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL

Autor:	Edwin Kingsley, Sebastian Grosicki, Michal Kwiatek, Antonio Salar, Sylvia Snauwaert, Ying Wang, Helena Adamis, Luqiang Wang, Julien Depaus
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 22:S163
ISSN:	2152-2650
DOI:	10.1016/s2152-2650(22)01001-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::82aa0438c985a3d731e61481f7e64fbb https://doi.org/10.1016/s2152-2650(22)01001-1 Zobrazit plný text záznamu Full Text from ScienceDirect